MZE-001
MZE-001 (compound 783) is a glycogen synthase 1 (GYS1) inhibitor. MZE-001 can be used for the study of GYS1 -mediated disease, such as Gaucher and Fabry diseases[1][2].
Product Specifications
CAS Number
[2839916-15-1]
UNSPSC
12352005
Target
Glycosyltransferase
Related Pathways
Epigenetics
Field of Research
Metabolic Disease
Smiles
O=C([C@H]1N(C[C@@H](C1)F)C(CN2C(C(F)F)=CC=N2)=O)N[C@@H](C3=CC=CC=C3)C4=CC=C(C(C)C)C(F)=N4
Molecular Formula
C26H27F4N5O2
Molecular Weight
517.52
References & Citations
[1]Gulsah Aydin. HIGH-AFFINITY BINDING OF DAPAGLIFLOZIN TO HUMAN GYS1: A STRUCTURE-BASED REPURPOSING STRATEGY FOR LAFORA DISEASE. id health scıence, 2025.|[2]David John Morgans, et al. Inhibitors of glycogen synthase 1 (gys1) and methods of use thereof. WO2022198196A1.
Shipping Conditions
Room temperature
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-156155/
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![PIK3AP1 Mouse Monoclonal Antibody [Clone:5H5]](https://cdn.genprice.uk/genprice/genprice2.png)
